P

Inventor

AREND MICHAEL P

US35 patents
⚠️ This page may combine multiple inventors who share the name “AREND MICHAEL P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FIBROGEN INC

27 patents
US7323475B2Jan 29, 2008

Nitrogen-containing heteroaryl compounds and methods of use thereof

FIBROGEN INC97 citations98
US7863292B2Jan 4, 2011

Nitrogen-containing heteroaryl compounds and methods of use thereof

FIBROGEN INC28 citations96
US7629357B2Dec 8, 2009

Nitrogen-containing heteroaryl compounds and methods of user thereof

FIBROGEN INC38 citations96
US8017625B2Sep 13, 2011

Nitrogen-containing heteroaryl compounds and methods of use thereof

FIBROGEN INC42 citations94
US7696223B2Apr 13, 2010

Pyrrolo- and Thiazolo-pyridine compounds, and methods of use thereof

FIBROGEN INC54 citations94
US9339527B2May 17, 2016

Nitrogen-containing heteroaryl compounds and methods of use thereof

FIBROGEN INC7 citations92
US8883823B2Nov 11, 2014

Crystalline forms of a prolyl hydroxylase inhibitor

FIBROGEN INC20 citations92
US8765956B2Jul 1, 2014

Nitrogen-containing heteroaryl compounds and methods of use thereof

FIBROGEN INC19 citations92
US10092558B2Oct 9, 2018

Nitrogen-containing heteroaryl compounds and methods of use thereof

FIBROGEN INC3 citations84
US9708269B2Jul 18, 2017

Process for making isoquinoline compounds

FIBROGEN INC6 citations84
US9617218B2Apr 11, 2017

Crystalline forms of a prolyl hydroxylase inhibitor

FIBROGEN INC5 citations84
US9371288B2Jun 21, 2016

Crystalline forms of a prolyl hydroxylase inhibitor

FIBROGEN INC7 citations84
US9340511B2May 17, 2016

Process for making isoquinoline compounds

FIBROGEN INC16 citations84
US9115085B2Aug 25, 2015

Crystalline forms of a prolyl hydroxylase inhibitor

FIBROGEN INC12 citations84
US9000006B2Apr 7, 2015

Thienopyridine compounds, and methods of use thereof

FIBROGEN INC7 citations84
US10927081B2Feb 23, 2021

Enhanced erythropoiesis and iron metabolism

FIBROGEN INC3 citations83
US9695170B2Jul 4, 2017

Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase

FIBROGEN INC5 citations83
US9271970B2Mar 1, 2016

Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase

FIBROGEN INC7 citations83
US10272078B2Apr 30, 2019

Crystalline forms of a prolyl hydroxylase inhibitor

FIBROGEN INC2 citations73
US10118897B2Nov 6, 2018

Crystalline forms of a prolyl hydroxylase inhibitor

FIBROGEN INC2 citations73
US9918977B2Mar 20, 2018

Crystalline forms of a prolyl hydroxylase inhibitor

FIBROGEN INC3 citations73
US9643928B2May 9, 2017

Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid

FIBROGEN INC4 citations73
US11680047B2Jun 20, 2023

Enhanced erythropoiesis and iron metabolism

FIBROGEN INC1 citations72
US9409892B2Aug 9, 2016

4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors

FIBROGEN INC6 citations71
US9387200B2Jul 12, 2016

Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity

FIBROGEN INC5 citations71
US11229637B2Jan 25, 2022

Nitrogen-containing heteroaryl compounds and methods of use thereof

FIBROGEN INC0 citations62
US10646482B2May 12, 2020

Nitrogen-containing heteroaryl compounds and methods of use thereof

FIBROGEN INC0 citations52

AREND MICHAEL P

4 patents

GUENZLER-PUKALL VOLKMAR

1 patent

NG DANNY

1 patent

ZHOU XIAOTI

1 patent

TURTLE ERIC D

1 patent